A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID).

JF, Colombel; M, Lémann; M, Cassagnou; Y, Bouhnik; B, Duclos; JL, Dupas; B, Notteghem; JY, Mary

doi:10.1111/j.1572-0241.1999.935_q.x

Public

A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID).

Shared by NobleBlocks on Mar 1, 1999 • 12:00 AM UTC

Authors:

Colombel JF

Lémann M

Cassagnou M

Abstract

Objective The aim of this randomized controlled study was to investigate the efficacy of ciprofloxacin compared with mesalazine in treating active Crohn's disease.Methods Patients with a mild to moderate flare-up of Crohn's disease (mean Crohn's Disease Activity Index [CDAI]; 217; range, 160-305) we...

Discussions